In our meta-analysis, the results of 24 studies involving 1453 patients demonstrated that the expression of MMP-2 in patients with high-grade gliomas increased significantly as compared to patients with low-grade gliomas, while no correlation was observed between MMP-2 and age, and also no association was found between MMP-2 and gender. Here, MMP2 is linked to glioma.